Saccharomyces boulardii is an intestinal flora replacement which acts as antidiarrheal microorganisms in the digestive tract. During transit under its viable form in the digestive tract, saccharomyces boulardii exerts biological actions which are similar to the protective properties of the normal intestinal flora.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A07FA02 | Saccharomyces boulardii | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| BIOFLOR Capsule, hard | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| BIOFLOR Powder for oral suspension | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
Saccharomyces boulardii is an active ingredient of these brands:
Austria (AT)
Cyprus (CY)
Estonia (EE)
Finland (FI)France (FR)
Germany (DE)
Hong Kong (HK)
Lithuania (LT)
Malta (MT)
Poland (PL)
Romania (RO)
Singapore (SG)
South Africa (ZA)Spain (ES)
Tunisia (TN)
Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
